FindTrial
Sign In

Evaluation of analgesic effect of Magnesium sulphate added to caudal bupivacaine in children operated for surgery below umblicus

Evaluation of analgesic efficacy of Magnesium Sulphate as an adjuvant to caudal bupivacaine in children undergoing lower abdominal surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018845
Enrollment
60
Registered
2019-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: bupivacaine: Caudal bupivacaine 0.25% 1ml/kg in caudal anaesthesia Control Intervention1: Magnesium Sulphate: 50 mg added with bupivacaine 0.25% (1ml/kg) in caudal anaesthesia

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA-I and II posted for lower abdominal surgery

Exclusion criteria

Exclusion criteria: Coagulation disorder Infection at site of block Allergy to drugs Preexisting neurological disorders

Design outcomes

Primary

MeasureTime frame
Duration of AnalgesiaTimepoint: 24 hours postoperatively—

Secondary

MeasureTime frame
Any side effects of procedureTimepoint: up to 24 hrs post operatively—

Countries

India

Contacts

Public ContactSantosh

RNT Medical College

drsanchoudhary@gmail.com9462102856

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026